• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Angelini Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imagingHypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging
    Hypervision Surgical
    29 Apr 2026

    Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging

    Hypervision Surgical develops imaging technology that provides real-time insights into tissue during surgery. Its platform enables surgeons to assess tissue physiology beyond what is visible to the human eye, supporting intraoperative decision-making.

    CoMind raises £75m funding led by Plural to bring non-invasive brain monitoring device to marketCoMind raises £75m funding led by Plural to bring non-invasive brain monitoring device to market
    CoMind
    21 Oct 2025

    CoMind raises £75m funding led by Plural to bring non-invasive brain monitoring device to market

    CoMind develops a non invasive brain monitoring device that provides continuous bedside data for critical care patients, aiming to improve treatment decisions without the risks of invasive probes.

Angelini Ventures
    • Health
  • 2(12 months)
  • angeliniventures.com
  • Update Information

More venture news

  • Silveray lands £5m Series A led by PXN Ventures to scale ultra-thin flexible X-ray film technology
    Silveray
    22 Jun 2026

    Silveray lands £5m Series A led by PXN Ventures to scale ultra-thin flexible X-ray film technology

    Series ADeep Tech
  • RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
    RQ Bio
    25 Jun 2026

    RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza

    Series ALife Sciences
  • Astral Systems unlocks £23m Series A led by Mercia Ventures to develop medical isotopes with multi-state fusion technology
    Astral Systems
    23 Jun 2026

    Astral Systems unlocks £23m Series A led by Mercia Ventures to develop medical isotopes with multi-state fusion technology

    Series ADeep Tech

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn